These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 3894536

  • 1. [Clinical significance of tumor associated antigen TA-4 in gynecologic tumors].
    Inoue Y, Ueda G, Yamasaki M, Inoue M, Tanaka Y, Hiramatsu K, Nishino T, Saito J, Abe Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):919-22. PubMed ID: 3894536
    [Abstract] [Full Text] [Related]

  • 2. [Determination of the SCC antigen in the serum of patients with cervical cancer].
    Crombach G, Würz H, Bolte A.
    Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):439-45. PubMed ID: 3623046
    [Abstract] [Full Text] [Related]

  • 3. [Tumor antigen TA-4 of squamous cell carcinoma in patients with cervical cancer].
    Kato H, Morioka H, Aramaki S, Tamai K, Nagaya T, Nagai M, Torigoe T.
    Gan No Rinsho; 1984 May; 30(6 Suppl):574-7. PubMed ID: 6748228
    [Abstract] [Full Text] [Related]

  • 4. Heterogeneous distribution of acidic TA-4 in cervical squamous cell carcinoma: immunohistochemical demonstration with monoclonal antibodies.
    Kato H, Suehiro Y, Morioka H, Torigoe T, Myoga A, Sekiguchi K, Ikeda I.
    Jpn J Cancer Res; 1987 Nov; 78(11):1246-50. PubMed ID: 3121560
    [Abstract] [Full Text] [Related]

  • 5. [Immunohistochemical studies on a new antigens associated with squamous cell cancer in oncogenesis of uterine cervical cancer].
    Uchimura M, Kenjo T, Kuroshima Y, Fujii A, Yamauchi S.
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jan; 43(1):73-9. PubMed ID: 1997617
    [Abstract] [Full Text] [Related]

  • 6. [The importance of the SCC antigen in the diagnosis and follow-up of cervix carcinoma. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)].
    Crombach G, Würz H, Herrmann F, Kreienberg R, Möbus V, Schmidt-Rhode P, Sturm G, Caffier H, Kaesemann H.
    Dtsch Med Wochenschr; 1989 May 05; 114(18):700-5. PubMed ID: 2714197
    [Abstract] [Full Text] [Related]

  • 7. [Prediction of the recurrence of squamous cell carcinoma of the uterine cervix by monitoring serum TA-4].
    Oishi T, Maruo T, Yamasaki M, Mochizuki M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 May 05; 39(5):799-806. PubMed ID: 3598275
    [Abstract] [Full Text] [Related]

  • 8. Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial determinations and tissue localization.
    Maruo T, Shibata K, Kimura A, Hoshina M, Mochizuki M.
    Cancer; 1985 Jul 15; 56(2):302-8. PubMed ID: 2408732
    [Abstract] [Full Text] [Related]

  • 9. [Expression of Thomsen-Friedenreich antigen (T-Ag) in gynecologic cancer tissues].
    Sakamoto Y, Kamada M, Shitsukawa K, Yasui T, Furumoto H, Mori K, Daitoh T, Irahara M, Kishi Y, Aono T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov 15; 39(11):1980-6. PubMed ID: 3429980
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix.
    Bolli JA, Doering DL, Bosscher JR, Day TG, Rao CV, Owens K, Kelly B, Goldsmith J.
    Gynecol Oncol; 1994 Nov 15; 55(2):169-73. PubMed ID: 7959279
    [Abstract] [Full Text] [Related]

  • 12. Relationship between squamous cell carcinoma antigen levels and tumor volumes in patients with cervical carcinomas undergoing neoadjuvant chemotherapy.
    Kim BG, Kim JH, Park SY, Lee JH, Lee ED, Lee KH, Park KB, Lee BH, Kim KH.
    Gynecol Oncol; 1996 Oct 15; 63(1):105-13. PubMed ID: 8898178
    [Abstract] [Full Text] [Related]

  • 13. Squamous cell carcinoma antigen in oral squamous cell carcinomas.
    Nagumo K, Okada N, Takagi M, Yamamoto H, Amagasa T, Fujibayashi T.
    Bull Tokyo Med Dent Univ; 1990 Jun 15; 37(1-2):27-34. PubMed ID: 2225283
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical demonstration of tumor antigen TA-4 in gynecologic tumors.
    Ueda G, Inoue Y, Yamasaki M, Inoue M, Tanaka Y, Hiramatsu K, Saito J, Nishino T, Abe Y.
    Int J Gynecol Pathol; 1984 Jun 15; 3(3):291-8. PubMed ID: 6389386
    [Abstract] [Full Text] [Related]

  • 15. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM, Wang PH, Yen MS, Lai CR, Ng HT, Yuan CC.
    Gynecol Oncol; 2000 Jan 15; 76(1):103-6. PubMed ID: 10620449
    [Abstract] [Full Text] [Related]

  • 16. [SCC (squamous cell carcinoma) antigen as a tumor marker in cervix cancers].
    Geyer H, Schwörer D, Pfleiderer A.
    Geburtshilfe Frauenheilkd; 1989 Mar 15; 49(3):266-71. PubMed ID: 2721888
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.